Expanding Medical and Non-Medical Applications to Stimulate Growth in the Global Biosensors Market, According to New Report by Global Industry Analysts, Inc. | The Knowledge Dynasty

Expanding Medical and Non-Medical Applications to Stimulate Growth in the Global Biosensors Market, According to New Report by Global Industry Analysts, Inc.

San Jose, California (PRWEB) November 12, 2014

Follow us on LinkedIn – A biosensor is an analytical bioelectronic device that captures the biological signal from analyte and translates these signals into measurable output. Given its ability to efficiently detect analytes, biosensor finds use in a broad range of end-use industries including medical diagnostics, general healthcare, environmental monitoring, and food and agriculture, among others. Expanding medical and non-medical applications, increasing investments in biosensor R&D initiatives, and development of novel technologies are driving growth in the market. Specifically, expanding diabetes population and the increasing emphasis on home care diagnostics are favoring growth.

Future growth in the market will be driven by increasing use in drug discovery, diabetes monitoring, environmental monitoring, agriculture, and bio-defense sectors. Technological advancements such as miniaturization and micro-fabrication are also enabling deeper penetration of biosensors into a wider range of application markets. Additionally, the shift towards telemetrics, growing popularity of micro-fluidics, developments in nanotechnology, molecular markers, surface characterization, and bio-complimentary chemistry, are all expected to significantly impact growth in the future. Nanotechnology is expected to play a vital role in biosensor development, owing to the unique optical, mechanical, physical and magnetic characteristics of nanomaterials such as graphene, carbon nanotubes, quantum dots, gold nanoparticles and nanowires.

Medical biosensors are expected to benefit from the high prevalence of diabetes worldwide and the ensuing focus on self-care in management of the disease. While blood glucose meters are the most widely sold biosensors, biosensors used in areas such as microbial, bio-molecular, and chemical detection are expected to make strong gains in the coming years. Use of biomarkers in other medical applications such as in oncology and cardiology is also helping lend significant traction to growth. Non-medical applications of biosensors such as in industrial control, environmental monitoring and bio-defense will bring in new opportunities for growth

As stated by the new market research report on Biosensors, the United States represents the largest market worldwide supported by aging population, sophisticated healthcare infrastructure, and increasing demand for point-of-care testing & monitoring as a result of the growing preference for alternate care sites. Asia-Pacific ranks as the fastest growing market with a CAGR of 13.9% over the analysis period. Growth in the region is driven by improved access to affordable healthcare services, improvement in per capita healthcare spends and growing healthcare awareness and focus on effective disease management.

Key players covered in the report include Abbott Point Of Care Inc., Animas Corporation, Bio-Rad Laboratories Inc., GE Healthcare Life Sciences, F. Hoffmann-La Roche Ltd, LifeScan Inc., Medtronic MiniMed Inc., Abtech Scientific Inc., Agamatrix Inc., Cambridge Life Sciences Limited, EMD Millipore Corporation, Innovative Biosensors Inc., I-Sens Ltd., Nova Biomedical Corp., PerkinElmer Inc., and Sigma Aldrich Corporation, among others.

The research report titled “Biosensors: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections in dollars for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific), and Rest of World. Product Group/Segment analyzed include Medical Biosensors (Glucose Biosensors and Other Medical Biosensors), Environmental Biosensors, and Other Biosensors.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Biosensors_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world’s largest and reputed market research firms.

Global Industry Analysts, Inc.

Telephone: 408-528-9966

Fax: 408-528-9977

Email: press(at)StrategyR(dot)com

Web Site: http://www.StrategyR.com/

###







Related Chemistry Press Releases

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Categories

Coursera

New Skills, New You: Transform your career in 2016 with Coursera

Follow us on Twitter